請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/24473完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 黃義侑 | |
| dc.contributor.author | Ming-Jhi Tzeng | en |
| dc.contributor.author | 曾明吉 | zh_TW |
| dc.date.accessioned | 2021-06-08T05:27:23Z | - |
| dc.date.copyright | 2005-07-21 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-15 | |
| dc.identifier.citation | 1. K. Fellinger, J. Schmidt, Klinik and Therapies des Chromischen Gelenkreumatismus, Maudrich Vienna, Austria (1954) 549–552.
2. 鄭俊民主編 經皮給藥新劑型 . 北京 人民衛生出版社1997.37. 3. Prausnitz MR, A practical assessment of transdermal drug delivery by skin electroporation. Adv Drug Deliv Rev. 1999 Jan 4;35(1):61-76. 4. Marcells GN, Ellis DA. Laser facial skin resurfacing: discussion on erbium:YAG and CO2 lasers. J Otolaryngol. 2000 Apr;29(2):78-82. Review. 5. 劉邦國 趙俊生 張魯峰(135醫院 膠州266300)皮膚用藥製劑及國內發展動態 前衛藥學雜誌2000年第14卷第2期 6. 童華 胡晉紅 范國榮 第二軍醫大學附屬長海醫院藥學部 低頻超聲導入法透皮給藥研究進展 7. G.L. Coodley, Bursitis and post-traumatic lesions. Am. Pract. 11 (1960), pp. 181–187. 8. B.M. Cameroy, Ultrasound enhanced local anesthesia. Am. J. Orthop. 8 (1966), p. 47. 9. J.E. Griffin, J.L. Echternach, R.E. Proce and J.C. Touchstone, Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. Phys. Ther. 47 (1967), pp. 600–601. 10. J.E. Griffin and J.C. Touchstone, Low-intensity phonophoresis of cortisol in swine. Phys. Ther. 48 (1968), pp. 1136–1344. 11. J.E. Griffin, J.C. Touchstone, Effects of ultrasonic frequency on phonophoresis of cortisol into swine tissues, Am. J. Phys. Med. 51 (1972) 62–78. 12. J.E. Griffin, Physiological effects of ultrasonica energy as it is used clinically. J. Am. Phys. Ther. Assoc. 46 (1966), pp. 18–26. 13. D. Levy, J. Kost, Y. Meshulam and R. Langer, Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J. Clin. Invest. 83 (1989), pp. 2074–2078. 14. D. Bommannan, G.K. Menon, H. Okuyama, P.M. Elias and R.H. Guy, Sonophoresis: II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm. Res. 9 (1992), pp. 1043–1047. 15. D. Bommannan, H. Okuyama, P. Stauffer and R.H. Guy, Sonophoresis: I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm. Res. 9 (1992), pp. 559–564. 16. K. Tachibana, Transdermal delivery of insulin to alloxan-diabetc rabbits by ultrasound exposure. Pharm. Res. 9 (1992), pp. 952–954. 17. K. Tachibana and S. Tachibana, Use of ultrasound to enhance the local anesthetic effect of topically applied aqueous lidocaine. Anestheiology 78 (1993), pp. 1091–1096. 18. K. Tachibana and S. Tachibana, Transdermal delivery of insulin by ultrasonic vibration. J. Pharm. Pharmacol. 43 (1991), pp. 270–271. 19. S. Mitragotri, D. Edwards, D. Blankschtein and R. Langer, A mechanistic study of ultrasonically enhanced transdermal drug delivery. J. Pharm. Sci. 84 (1995), pp. 697–706. 20. S. Mitragotri, D. Blankschtein and R. Langer, Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res. 13 (1996), pp. 411–420. 21. S. Mitragotri and J. Kost, Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound. Pharm. Res. 18 (2000), pp. 1151–1156. 22. A. Boucaud, M.A. Garrigue, L. Machet, L. Vaillant and F. Patat, Effect of sonication parameters on transdemral delivery of insulin to hairless rats. J. Pharm. Sci. 91 (2002), pp. 113–119. 23. A. Tezel, A. Sens and S. Mitragotri, A theoretical description of transdermal transport of hydrophilic solutes induced by low-frequency sonophoresis. J. Pharm. Sci. 92 (2003), pp. 381–393. 24. Benson H,Mcelnay J,Harland R.Phonophoresis of lignocaine and prilocaine from emla cream.Inter.J.Pharm,1988,44:65 25. Asano J,Suisha F,Takada M,et al.Effect of pulse ultrasound on the transdermal absorption of indomethacin from an ointment in rats.Biom Pharm Bull,1997,20(3):288 26. Shozo Miyazaki,Yumi Kokata,Masahiko Takada.Effect of ultrasound on transdermal absorption of indomethcin-continuous mode and pulse mode.Yakuzaigaku,1992,52(4):264 27. Meidan V,Walmsley A,Iriwin W.Phonophoreis it a reality? Inter J Pharm Sci,1995,118:129 28. A. Tezel, A. Sens, J. Tuscherer and S. Mitragotri, Frequency dependence of sonophoresis. Pharm. Res. 18 (2001), pp. 1694–1700. 29. Shozo Miyazaki,Yimi Kohata,Masahiko Takada.Effect of ultrasound on the transdermal absorption of nonsteroidal anti-inflammatory drug from toptical formulations.Yakuzaigaku,1993,53(4):277 30. Ueda H,Ogihara M,Sugibayashi K,et al.Difference in the enhancing effects of ultrasound on the skin permeation of polar drugs.Chem Pharm Bull Tokyo,1996,44(10):1 973 31. Mitragotri S, Kost J. Low-frequency sonophoresis: a review. Adv Drug Deliv Rev. 2004 Mar 27;56(5):589-601. Review. 32. Tang H, Mitragotri S, Blankschtein D, Langer R. Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis. J Pharm Sci. 2001 May;90(5):545-68. 33. K.S. Suslick, Ultrasound: Its Chemical, Physical and Biological Effects. , VCH Publishers (1989). 34. A. Tezel, A. Sens and S. Mitragotri, Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J. Pharm. Sci. 91 (2002), pp. 444–453. 35. H. Tang, D. Blankschtein and R. Langer, An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm. Res. 19 (2002), pp. 1160–1169. 36. 害怕打針的救星 ─ EMLA 藥膏 打針的恐懼台大醫學院麻醉科副教授兼主治醫師 范守仁http://an.mc.ntu.edu.tw/lifecare/common_med/emla.htm 37. 詹廖明義,'哈日族的醫學常識',正義出版社,P14~P15。 38. 許淑蓮,'當代外科護理',華杏出版股份有限公司,P35~P72。 39. 神經傳導速度與肌電圖檢查台大醫院神經部李靜娥醫師http://med.mc.ntu.edu.tw/~neuro/4_educate_77.htm 40. L. Machet , A. Boucaud. Phonophoresis: efficiency, mechanisms and skin tolerance. International Journal of Pharmaceutics 243 (2002) 1–15 41. 職業病認定參考性評估方法-以腕隧道症候群為例財團法人仁愛綜合醫院疼痛科詹廖明義醫師 台灣疼痛治療資訊網 http://www.pain-manage.org.tw/professional/a41.htm 42. M.G.Bjorksten, B.BOQUIST, M.Talback,C.Edling,“The validity of reported musculoskeletal problems.A study of questionnaire answers in relation the diagnosed disorders and perception of pain”,Applied Ergonomics 30(1999)325-330 43. FREDERIC J. KOTTKE,M.D. ,G. KEITH STILLWELL, M.D.,JUSTUS F.LEHMANN,M.D.編著,楊榮森 譯 ,74年1月初版;合記圖書出版社,“復健醫學”。 44. Copyright 1999 Northern Arizona University ALL RIGHTS RESERVED http://jan.ucc.nau.edu/~cornwall/pt580/class/EDX/NCV/assign2-3-1.html 45. http://bmeimage.cycu.edu.tw/database/ultrasound3/ultrasound3.html | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/24473 | - |
| dc.description.abstract | 所謂藥物經皮吸收系統(trandermal therapeutic systems,TTS)是指在皮膚表面給藥,使藥物以恒定速度(或接近恒定速度)通過皮膚各層,進入體循環產生全身或局部治療作用的新方法。經皮給藥是除了口服給藥外最為大家所接受的給藥方式,到目前為止人體in vivo經皮超音波導入法的實驗並無法得到確切的數據,驗證有滲透效果。
局部麻醉藥具止痛效果,疼痛是一種個體的主觀體驗,它受文化水準,生活背景、注意力和其他心理學變量的影響。每一個人對於『疼痛』的感受皆不相同。現行疼痛的評估最常使用的為等級法、問卷及疼痛圖形,這些方式都屬於主觀體驗。本研究採取pretreatment超音波導入法,針對如何讓藥物透過皮膚角質層做各種研究,藉由各種儀器(如壓痛計、痛覺測試儀、神經傳導檢查及肌電圖量測儀NCV/EMG)量測各種訊號,希望能藉由超音波導入法降低EMLA的給藥時間,得到量化數據,在不傷害人體皮膚前提下,並探討影響超音波導入的因素及取得超音波導入藥物的人體模式,做一分析並得到不經傳統量測疼痛方式而取得相關神經電位振幅及latency變化來驗證是否有超音波增進導入的效果。 尤其是我們利用神經傳導檢查及肌電圖量測儀NCV/EMG,感覺神經傳導檢查主要用於周邊神經病變鑑別診斷,利用感覺神經傳導檢查,完全由機器觸發電流,減少人為因素干擾,用電位訊號振幅變化大小或神經傳導速度的快慢變化,來驗證神經是否有麻醉藥物導入,去證明超音波是否能加速麻醉藥物導入,可避免疼痛量測時主觀意識所造成的誤差,並取得客觀科學數據,提供感覺神經傳導檢查在疼痛的評估另一個思考方向,也可以驗證超音波增進導入的效果。 | zh_TW |
| dc.description.abstract | There are numerous passive and active methods of administering drugs to the body. Active methods include the use of penetration enhancers and assisted drug delivery and One of them is sonophoresis (phonophoresis). Topical anesthetics can be used to reduce the local pain and the distress caused by venipuncture, injections, lumbar punctures, arterial blood gases, and other cutaneous procedures. About this treatment, Not only adults but also children dislike it. However, these agents(EMLA) require at least ¬60 minutes to achieve acceptable anesthesia. Application of brief 1 M Hz frequency ultrasound (Ultrasonic Skin Firmer KUM-2000 pulse wave Duty cycle 5:5 Intensity 1.5 W/cm2 90% 5 minute) has been shown to de¬crease the time to onset of EMLA analgesia in healthy controls from 60 minutes to 20-30 minutes. (EMLA , Eutectic Mixture of Local Anesthetics , Lidocaine 2.5% & Prilocaine 2.5%)
Traditionally , the measurement of the pain has been subjective, Hence we are trying to find more efficient ways,so we use NCV(Nerve Conduction Velocity)in sonophoresis to achieve the goal. One of the NCV, sensory nerve conduction studies, could record the surface electrodes are used to record action potentials whose amplitude is only a few tens of microvolts and nerve conduction velocity variability.(Comparison of the latencies of responses evoked by stimuli at different places along the nerve allows the conduction velocity of the fastest sensory fibres to be determined.) The objective of this study was to demonstrate that ultrasound treatment followed by brief application of topical anesthetic decreases the perception of the patients’ pain caused by the treatment of IV cannulation. We utilize the method of NCV to measure variability of the latency. We get a real biological signal which is not a pain score.It can avoid getting as subjective data as possible.To use pretreatment with ultrasound to the skin increases permeation rates of hydrophobic topical medications, including topical EMLA. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T05:27:23Z (GMT). No. of bitstreams: 1 ntu-94-R92548005-1.pdf: 1495971 bytes, checksum: 330bc4588944d8d171415ff1473a0078 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 壹、 前言………………………………………………………1
貳、 文獻回顧…………………………………………………4 一、 皮膚生理結構和藥物經皮吸收途徑……………………4 二、 藥物經皮吸收途徑………………………………………6 三、 非侵入式經皮給藥方式…………………………………7 四、 影響超音波導入的因素…………………………………14 五、 超音波導入促進滲透的機制……………………………18 六、 超音波治療作用…………………………………………21 七、 超音波使用的安全性……………………………………22 八、 量測痛覺方法……………………………………………23 九、 EMLA藥膏…………………………………………………25 十、 局部麻醉藥作用…………………………………………28 參、 材料與方法………………………………………………30 一、 材料………………………………………………………30 二、 超音波美白導入儀校正…………………………………31 三、 實驗基本方法……………………………………………36 四、 量測位置選擇手部神經…………………………………36 五、 方法一痛覺測試儀量測…………………………………38 六、 方法二壓痛計量測………………………………………41 七、 方法三壓痛計量測placebo方式……………………….42 八、 方法四神經傳導檢查量測橈神經………………………42 九、 方法五神經傳導檢查量測正中神經……………………44 十、 方法六神經傳導檢查量測尺神經背側支處……………46 十一、 方法七神經傳導檢查量測尺神經皮膚較薄處…………46 十二、 方法八神經傳導檢查量測尺神經經過位置(超音波設定條件為頻率1 MHz,pulse wave,Duty cycle 5:5,能量1.5 W/cm2,90%,時間5分鐘。)………………………………………………48 十三、 方法八神經傳導檢查量測尺神經經過位置(超音波設定條件為頻率1 MHz,pulse wave,Duty cycle 5:5,能量0.8 W/cm2,90%,時間5分鐘。)………………………………………………50 肆、 結果與討論………………………………………………51 一、 方法一痛覺測試儀量測結果結果與討論………………51 二、 方法二壓痛計量測的結果與討論………………………51 三、 方法三壓痛計量測placebo方式的結果與討論……….52 四、 神經傳導檢查……………………………………………53 五、 方法四神經傳導檢查量測橈神經的結果與討論………58 六、 方法五神經傳導檢查量測正中神經的結果與討論……59 七、 方法六神經傳導檢查量測尺神經背側支處的結果與討論…………………………………………………………………….60 八、 方法七神經傳導檢查量測尺神經皮膚較薄處的結果與討論…………………………………………………………….………61 九、 方法八神經傳導檢查量測尺神經經過位置的結果與討論(超音波設定條件為頻率1 MHz,pulse wave,Duty cycle 5:5,能量1.5 W/cm2,90%,時間5分鐘。)…………………………….64 十、 方法八神經傳導檢查量測尺神經經過位置(超音波設定條件為頻率1 MHz,pulse wave,Duty cycle 5:5,能量0.8 W/cm2,90%,時間5分鐘。)……………………………………………….73 伍、 結論與未來發展………………………………………….78 一、 結論……………………………………………………….78 二、 未來發展………………………………………………….79 陸、 參考文獻………………………………………………….81 | |
| dc.language.iso | zh-TW | |
| dc.subject | 局部麻醉藥 | zh_TW |
| dc.subject | 神經傳導檢查 | zh_TW |
| dc.subject | 超音波 | zh_TW |
| dc.subject | skin permeation | en |
| dc.subject | sonophoresis | en |
| dc.title | 超音波刺激藥物經皮的滲透研究 | zh_TW |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 王正一,陸哲駒 | |
| dc.subject.keyword | 超音波,神經傳導檢查,局部麻醉藥, | zh_TW |
| dc.subject.keyword | sonophoresis,skin permeation, | en |
| dc.relation.page | 86 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2005-07-15 | |
| dc.contributor.author-college | 工學院 | zh_TW |
| dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
| 顯示於系所單位: | 醫學工程學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 未授權公開取用 | 1.46 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
